[PRESS RELEASE] Biofortis and ProDigest announce an agreement for a global collaboration in the field of Gastrointestinal Research

 

Ghent, Belgium and Saint-Herblain, France 

Oct. 23, 2020 – ProDigest, specialists in intestinal research and Biofortis, Mérieux NutriSciences’ Contract Research Organization serving innovation in nutrition, health, and microbiota studies, enter into a global agreement to strengthen and enlarge their international services. Their joint expertise in the field of gastrointestinal transit, bioavailability, metabolism, immune modulation and efficacy of food compounds, functional ingredients and pharmaceuticals offers broader and more efficient support to customers in their development of drugs, pre- and probiotics and food ingredients

Combining the know-how in preclinical testing developed by ProDigest and the expertise in clinical trials and microbiome analysis of Biofortis, we can now manage global projects evaluating novel bioactive candidates for their functionality, safety, effectiveness, impact on the gut microbiome and mechanism of action. 

Etienne Casal, Senior Vice-president Europe of Mérieux NutriSciences and Benoit Fouchaq, Managing Director of Biofortis, commented:

“We are pleased to collaborate with our colleagues at ProDigest to facilitate and accelerate the development of the future drugs and products in the field of gastrointestinal research. This collaboration will also stimulate innovation by sharing R&D projects.”

Massimo Marzorati, CEO of ProDigest, added:

“We are excited about this opportunity. The research area around the human gut is rapidly evolving as witnessed by the requests we receive from our clients around the world. The collaboration with Biofortis will create an innovative supply chain in which in vitro and in vivo data will be merged to provide a unique insight on the efficacy and functionality of new actives in the food and pharma market.”

About Biofortis

Based in Europe, USA and Asia, Biofortis combines an experienced and GCP-trained staff with a strong network of scientists and key opinion leaders in various study fields such as cardiovascular, metabolic, exercise physiology, cognitive function, satiety and weight management. In addition, and with the Next Generation Sequencing (NGS) platform and bioinformatics solutions, Biofortis can characterize the different microbiomes and evaluate the safety and the efficacy of new candidate or new products. 

About ProDigest

ProDigest is a CRO focused on preclinical gastrointestinal research. At the centre of each project is the SHIME® technology platform, the Simulator of the Human Intestinal Microbial Ecosystem. This unique in vitro gastrointestinal simulator accurately recreates physiology and microbiology of the whole gastrointestinal tract of humans and animals under healthy and diseased condition. 

Press contact: 

For ProDigest:

Massimo Marzorati

info@prodigest.eu 

 

For Biofortis: 

Clémence Chesneau 

biofortis-contact@mxns.com 

 

Image 7: 

Claire Doligez

cdoligez@image7.fr 

+33 1 53 70 74 48

 

Laurence Heilbronn:

lheilbronn@image7.fr 

+33 1 53 70 74 64

VITAFOODS 2024

May 14/15/16th, 2024in Geneva, Swiss[EVENT] - Biofortis will be present at Vitafoods Europe 2024   For this 2024 edition, we will be present together with analyze & realize, one of the leading...

[EVENT] – Biofortis will be present at PHARMABIOTICS 2024 

March 12/13/14th, 2024in Lille, France For this 2024 edition, Biofortis will be present during the Pharmabiotic Research Institute (PRI)'s annual conference in LILLE, France, 12/13/14 March 2024.  ...

Perform a user experience study under expert control

What is a user experience study? As a clinical research expert, Biofortis can also conduct other types of studies, namely user experience studies. If you have a product to promote (functional...

Biofortis will be present at PROBIOTA 2024 – Supporter level sponsor

Feb. 7th to 9th, 2024in Milan, ITALYCome and meet us at PROBIOTA in Milan, Italy.Probiota 2024, the leading Microbiome and must attend industry event will take place in the design capital of the...

[EVENT] Biofortis will be present at FIE

Nov. 28th to 30th, 2023in Frankfurt, GERMANYCome and meet us at Food Ingredients Europe (FIE) in Frankfurt, Germany.Fi Europe is the world's largest gathering of F&B ingredient buyers and...

[PRESS RELEASE] Biofortis strengthens its service offerings with the acquisition of analyze & realize

We are excited to announce that Biofortis, a leading European premium CRO has completed the acquisition of analyze & realize GmbH.    Based in Berlin, with more than 20 years’ experience in...

[EVENT] Biofortis will be present at NUTREVENT – SILVER SPONSOR 

October 17th & 18th 2023in Rennes, FRANCECome and meet us at NutrEvent in Rennes, France.As the European leading partnering event, NutrEvent is dedicated to innovation in Food, Human and Animal...

[NEWS] ACCELERATE YOUR ASSAYS

In a continuous improvement of our performance and analytical capabilities that's complements Biofortis Central lab, our expert staff members have worked to implement a new machine: LUMINEX LX-200. ...

[EVENT] Biofortis will be present at Outsourcing In Clinical Trials Europe 2023

May 3rd and 4th, 2023in Barcelona, SpainCome and meet us at the Outsourcing In Clinical Trials (OCT) Europe 2023 in Barcelona; Spain.   This event will provide participants with practical take-away...

[EVENT] Biofortis will be present at Vitafoods Europe 2023

May 9th to 11th, 2023in Geneva, SwitzerlandFor this 2023 edition, Vitafoods Europe 2023 will take a hybrid format: we will be present both virtual and in person, in Geneva, Switzerland. Vitafoods...